|
|
CME Information TARGET AUDIENCE This activity is targeted to any clinician with interest in education on migraine, including primary care physicians, nurse practitioners, physician assistants, emergency room physicians, and pediatricians. RELEASE/EXPIRATION DATE This enduring material will be available beginning September 16, 2021 through September 16, 2024. LEARNING OBJECTIVES After participating in this educational activity, participants should be better able to: Module 2: Secondary Headache Disorders in Primary Care
METHOD OF PARTICIPATION To receive credit for this activity, the participant must read the CME information (including learning objectives and disclosures) and participate in the entire activity (all 4 modules). Upon finishing the activity, the participant will need to complete the session post-test, evaluation, and all required personal information. To receive CME certificate, participant will need to pass the post-test with 75% accuracy or better. If participant receives less than 75%, participant should review the activity and take the test again. After successful completion of the activity, participant will receive a framed copy of their CME certificate in the mail within 10-14 days, as well as an emailed copy of their certificate to submit to their appropriate licensing boards. ACCREDITATION/DESIGNATION STATEMENTS This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the National Headache Foundation. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians. Primary Care Network designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2 hours of Category 1 credit for completing this program. Nurse Practitioners/Nurses The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Other Healthcare Professionals All other healthcare professionals will receive a certificate of participation. UNLABELED USE DECLARATION During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use. DISCLAIMER The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporters. ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT This activity is supported by educational grants provided by AbbVie, Amgen, Biohaven Pharmaceuticals, and Lilly. FACULTY/PLANNING COMMITTEE DISCLOSURES All relevant financial relationships have been mitigated for this activity. Vincent Martin, MD – Faculty/Content Developer – Module 1 President, National Headache Foundation Director, Headache and Facial Pain Center University of Cincinnati College of Medicine Advisory Board: Lundbeck Consultant: Abbvie, Amgen, Lilly, Biohaven, Theranica Research Grants: Abbvie, Amgen, Lilly, TEVA Speaker’s Bureau: Amgen, Lilly, Biohaven, TEVA Merle Diamond, MD – Faculty/Content Developer – Module 2 Director, Diamond Headache Clinic Chicago, IL Advisory Board/Consultant: Allergan/Abbvie, Amgen, Axsome, Biohaven, Impel NeuroPharma, Lilly, Lundbeck, TEVA Research Grants: Allergan/Abbvie, Amgen, Lilly, Lundbeck, TEVA Speaker’s Bureau: Allergan/Abbvie, Amgen, Axsome, Biohaven, Lilly, Lundbeck, TEVA Jan Lewis Brandes, MD – Faculty/Content Developer – Module 3 Director & Founder, Nashville Neuroscience Group Assistant Professor, Neurology Vanderbilt University Advisory Board: Amgen, Lilly, TEVA, Lundbeck, Impel, Theranica Consultant: Amgen, Lilly, Lundbeck, Impel, TEVA Research Grants: Amgen, Lilly, Allergan, TEVA, Biohaven Speaker’s Bureau: Lilly, Amgen, TEVA, Lundbeck, Allergan Paul G. Mathew, MD – Faculty/Content Developer – Module 4 Assistant Professor of Neurology Harvard Medical School Board Certified Headache Specialist Advisory Board & Consultant: Allergan, Amgen, Biohaven, Lilly, Revance The following individuals have no relevant financial relationships: Brian Koffman, MD – Reviewer Chief Medical Officer, CLL Society Jill Hays, CHCP – Planner Executive Director, Primary Care Network Cindy Fisher – Planner CME Program Manager, Primary Care Network This activity is accredited by Primary Care Network. |